Pfs230D1-EPA/Matrix-M
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Pfs230D1-EPA/Matrix-M, covering 2024-05-06 to 2024-05-06. Get the full timeline:
Most recent: Clinical Trial Update: Study of the Transmission-Blocking Vaccine Pfs230D1-EPA/Matrix-M Against Malaria in Adults in Mali [Phase 1]